[Morphological features of the thymus in heliotrin hepatitis upon administration of immunostimulators].
Kasymova. G G GG; Tukhtaev. K R KR
Key Findings
- Thymalin reduced the destruction of thymus cells in a hepatitis model.
- It increased the mitotic (division) activity of thymocytes.
- The protective effect slowed, but did not completely stop, thymus shrinkage (hypoplasia).
Practical Outcomes
- Thymalin may offer modest immune‑support benefits during acute stress or injury, but the evidence is limited to an animal disease model. For biohackers, it suggests a potential adjunct for immune health, yet dosing, timing, and real‑world efficacy remain unclear, so it should be considered experimental rather than a proven protocol.
Summary
In a liver injury model, the peptide thymalin (along with another immunostimulant) helped protect the thymus gland by reducing cell loss and encouraging cell division, but it didn't fully restore normal thymus structure. The benefit was seen regardless of when the peptide was given relative to the injury.
Abstract
Structural changes of thymus in heliotrin hepatitis were characterized by distinct dynamics which on the whole suggested the progressing hypoplasia of its cortex. Immunostimulants parandin and thymalin suppressed the extent of thymocyte destruction and stimulated their mitotic activity. Although these parameters did not reach the control levels, the significant deceleration of hypoplastic processes in thymus, particularly in its cortex, were detected. Effect of immunostimulants was independent on the time of their administration in respect to heliotrin injection.
Study Information
pubmed
2001